Illumina CapEx decreased by 30.9% to $38.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.8%, from $32.00M to $38.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows a downward trend with a -8.2% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $44.00M | $52.00M | $70.00M | $61.00M | $71.00M | $66.00M | $88.00M | $52.00M | $47.00M | $45.00M | $51.00M | $36.00M | $31.00M | $32.00M | $29.00M | $32.00M | $30.00M | $31.00M | $55.00M | $38.00M |
| QoQ Change | — | +18.2% | +34.6% | -12.9% | +16.4% | -7.0% | +33.3% | -40.9% | -9.6% | -4.3% | +13.3% | -29.4% | -13.9% | +3.2% | -9.4% | +10.3% | -6.3% | +3.3% | +77.4% | -30.9% |
| YoY Change | — | — | — | — | +61.4% | +26.9% | +25.7% | -14.8% | -33.8% | -31.8% | -42.0% | -30.8% | -34.0% | -28.9% | -43.1% | -11.1% | -3.2% | -3.1% | +89.7% | +18.8% |